Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 48701-48750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07204392
Unveiling the Germline Predisposition to Myeloproliferative Neoplasms
N/ARecruiting
313 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05156385
Sexual Dysfunction in Hypertensive Women
NARecruiting
348 participants
Started: Jun 27, 2022 · Completed: Jul 7, 2026
1 condition1 sponsor1 location
NCT06088628
Micro-expressions in Patients With Prolonged Disorders of Consciousness
N/ARecruiting
200 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06180785
Performance Evaluation of the Biological Diagnosis of HIT
N/ARecruiting
894 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05143177
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
PHASE2/PHASE3Recruiting
580 participants
Started: Jun 27, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor25 locations
NCT06416865
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
PHASE3Recruiting
190 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT05402696
St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
N/ARecruiting
3,500 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2032
3 conditions1 sponsor3 locations
NCT05378087
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
NARecruiting
1,956 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05000021
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
NARecruiting
93 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors2 locations
NCT05517811
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
N/ARecruiting
400 participants
Started: Jun 26, 2022 · Completed: Jul 31, 2028
7 conditions2 sponsors1 location
NCT05322967
Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs
NARecruiting
120 participants
Started: Jun 25, 2022 · Completed: Jun 1, 2025
3 conditions2 sponsors3 locations
NCT05890846
Precision TMS Treatment Guided by Personalized Brain Functional Sectors (pBFS) for ASD
NARecruiting
66 participants
Started: Jun 25, 2022 · Completed: Sep 20, 2025
1 condition3 sponsors2 locations
NCT05285553
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
NARecruiting
900 participants
Started: Jun 25, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor30 locations
NCT05377970
Implementation of a Prehabilitation Program for Surgical Patients
NARecruiting
20 participants
Started: Jun 25, 2022 · Completed: Jul 31, 2024
3 conditions2 sponsors1 location
NCT05404906
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
PHASE2/PHASE3Recruiting
124 participants
Started: Jun 25, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor2 locations
NCT05635630
Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention
NARecruiting
110 participants
Started: Jun 24, 2022 · Completed: Dec 24, 2025
3 conditions2 sponsors1 location
NCT05297734
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
NARecruiting
2,996 participants
Started: Jun 24, 2022 · Completed: Feb 28, 2028
2 conditions2 sponsors17 locations
NCT05780099
Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics
N/ARecruiting
50,000 participants
Started: Jun 24, 2022 · Completed: Sep 10, 2032
8 conditions1 sponsor2 locations
NCT05523245
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
N/ARecruiting
1,700 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2027
1 condition4 sponsors4 locations
NCT05212792
Genomics and COVID-19 Vaccine Adverse Events
N/ARecruiting
6,325 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06135987
Clinical Evaluation in Real Life of TLC-NOSF Dressings in the Local Treatment of Chronic Wounds (DFU and VLU)
N/ARecruiting
600 participants
Started: Jun 24, 2022 · Completed: Oct 31, 2024
5 conditions1 sponsor1 location
NCT06754423
Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency
N/ARecruiting
30 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05338632
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
PHASE1Recruiting
24 participants
Started: Jun 24, 2022 · Completed: Oct 1, 2026
2 conditions2 sponsors1 location
NCT05417594
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
PHASE1/PHASE2Recruiting
695 participants
Started: Jun 24, 2022 · Completed: Jun 1, 2027
1 condition1 sponsor33 locations
NCT05421767
Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
PHASE4Recruiting
60 participants
Started: Jun 24, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
PHASE1Recruiting
18 participants
Started: Jun 24, 2022 · Completed: Jun 30, 2027
3 conditions3 sponsors3 locations
NCT05400733
Prandial Metabolic Phenotype in Adults
NARecruiting
50 participants
Started: Jun 24, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
N/ARecruiting
500 participants
Started: Jun 23, 2022 · Completed: Oct 31, 2026
12 conditions7 sponsors3 locations
NCT05346354
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
PHASE2/PHASE3Recruiting
12 participants
Started: Jun 23, 2022 · Completed: Jan 2, 2029
1 condition1 sponsor21 locations
NCT05430035
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
EARLY_PHASE1Recruiting
10 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2029
1 condition1 sponsor1 location
NCT03642795
Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology)
N/ARecruiting
150 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor4 locations
NCT05226494
Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
PHASE1Recruiting
34 participants
Started: Jun 23, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05177679
Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption
NARecruiting
288 participants
Started: Jun 23, 2022 · Completed: Apr 30, 2026
3 conditions3 sponsors1 location
NCT05436093
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
NARecruiting
15 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05085028
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE3Recruiting
1,750 participants
Started: Jun 23, 2022 · Completed: May 31, 2027
1 condition4 sponsors37 locations
NCT05040204
The Effects of Dietary Supplementation on Serum Protein Glycosylation
PHASE1Recruiting
44 participants
Started: Jun 23, 2022 · Completed: Sep 1, 2025
1 condition3 sponsors1 location
NCT04786821
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
NARecruiting
24 participants
Started: Jun 23, 2022 · Completed: Oct 30, 2024
6 conditions1 sponsor1 location
NCT05324280
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
NARecruiting
68 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06082661
Blood Collection for COM/BSBS
N/ARecruiting
5,000 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04113382
Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 23, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT05327647
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
PHASE2Recruiting
160 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors7 locations
NCT05479123
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
PHASE4Recruiting
174 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05062291
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
N/ARecruiting
500 participants
Started: Jun 23, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor40 locations
NCT05378204
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
NARecruiting
120 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors25 locations
NCT05457985
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
NARecruiting
430 participants
Started: Jun 23, 2022 · Completed: May 31, 2026
1 condition2 sponsors13 locations
NCT05489575
CPAP for the Treatment of Supine Hypertension
NARecruiting
59 participants
Started: Jun 23, 2022 · Completed: Aug 31, 2026
6 conditions2 sponsors1 location
NCT05349227
Comprehensive Outcomes for After Cancer Health
NARecruiting
625 participants
Started: Jun 23, 2022 · Completed: May 31, 2027
11 conditions12 sponsors7 locations
NCT05521438
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
PHASE2/PHASE3Recruiting
30 participants
Started: Jun 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05237453
Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer
NARecruiting
30 participants
Started: Jun 23, 2022 · Completed: Mar 1, 2027
1 condition4 sponsors3 locations
NCT05440825
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
NARecruiting
171 participants
Started: Jun 23, 2022 · Completed: Sep 30, 2026
1 condition3 sponsors5 locations